In the past one year, the Nifty Pharma Index has shed 12.4% as against the 1% gains in the benchmark Nifty 50. Mutual Funds that bet on pharma stocks have fallen 14.2% on an average in the past one year. So far in 2022, they have declined 12.4% on an average, according to Value Research.
Market in a phase of time correction; recovery to be gradual: Sanjay H Parekh
A little unfortunate is that our growth rate in this quarter will be flattish. We are coming out of low growth and this year, full